Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,001 - 1,050 out of 12,188

Document Document Title
WO/2007/091009A2
It comprises a process for the production of delmopinol or a pharmaceutically acceptable salt and/or a solvate thereof, by subjecting the compound of formula (II) where R1 and R2 are the same or different, independently selected from the...  
WO/2007/092961A3
This invention provides compositions which are l,3-oxazinan-2-one compounds of formulae (I) and (II), and oxazolidinone compounds of formula (III): wherein R is a hydrocarbyl group, a heterocyclic group, a hydrocarbyl group having at lea...  
WO/2007/092961A2
This invention provides compositions which are l,3-oxazinan-2-one compounds of formulae (I) and (II), and oxazolidinone compounds of formula (III): wherein R is a hydrocarbyl group, a heterocyclic group, a hydrocarbyl group having at lea...  
WO/2007/091313A1
A heterocyclic phenoxy derivative represented by the formula (1a): (1a) wherein Y represents an oxygen or sulfur atom; (R1)m represents a hydrogen or halogen atom, an alkyl group or the like; (R2)n represents a hydrogen or halogen atom, ...  
WO/2007/092190A2
The present invention relates to compounds which modulate the activity of the SlPl receptor, the use of these compounds for treating conditions associated with signaling through the SlPl receptor, and pharmaceutical compositions comprisi...  
WO/2007/092190A3
The present invention relates to compounds which modulate the activity of the SlPl receptor, the use of these compounds for treating conditions associated with signaling through the SlPl receptor, and pharmaceutical compositions comprisi...  
WO/2007/087906A1
The present invention relates to N-cycloalkyl-benzyl-amide derivatives of formula (I) wherein the substituents are as in the description, their process of preparation, their use as fungicide active agents, particularly in the form of fun...  
WO/2007/089548A3
Disclosed are compositions and methods for modulating protein trafficking and treating or preventing disorders characterized by impaired protein trafficking. Also disclosed are methods for identification of compounds that rescue protein ...  
WO2007014290B1
This invention is directed to compounds of Formula (1) including all geometric and stereoisomers, N oxides, and agriculturally suitable salts thereof, agricultural compositions containing them and their use as fungicides, (1) provided th...  
WO/2007/089044A1
Disclosed is a process for production of an aromatic compound represented by the formula (3), wherein the process comprises reacting a compound represented by the formula (1) with an olefin compound represented by the formula (2) in the ...  
WO/2007/086584A1
Disclosed is a compound which can inhibit both of FabI and FabK which are fatty acid synthases to show a wide antibacterial spectrum including Streptococcus pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, and therefore can ...  
WO/2007/085203A1
The substituted pentabasic azaheterocyclic compounds of formula I and/or its pharmacological salts and hydrates are provided in the present invention, the groups in the formula are defined as the description. The medicinal composition co...  
WO/2007/085202A1
Compounds represented by the general formula I, their pharmaceutically acceptable salts, solvates are disclosed. The definitions of substituents of formula I are the same as description. The pharmaceutical compositions containing the com...  
WO/2007/083320A2
The present invention relates to the preparation of aryl hydrazines and their salts by treating aryl diazonium salts with triphenyl phosphine followed by hydrolysis of the resulting triphenyl-aryl hydrazyl phosphonium salt to get aryl hy...  
WO/2007/083320A3
The present invention relates to the preparation of aryl hydrazines and their salts by treating aryl diazonium salts with triphenyl phosphine followed by hydrolysis of the resulting triphenyl-aryl hydrazyl phosphonium salt to get aryl hy...  
WO/2007/081571A3
Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing athero...  
WO/2007/079928A1
The invention relates to substituted oxazole derivatives of formula (I), to a method for their production, to medicaments containing said compounds and to the use of substituted oxazole derivatives for producing medicaments.  
WO/2007/080882A1
Disclosed is a novel raw material compound which is useful for producing a novel cycloalkanecarboxamide derivative having a cathepsin K inhibitory activity. Specifically disclosed is an oxazolone derivative represented by the following f...  
WO/2007/081479A1
Diraromatic amine derivatives having the general formula: (I) wherein n is from 0 to 5; m is from 0 to 4; each R substituent is independently hydrogen or a straight or branched C1-C32 alkyl group or alkenyl group or two R substituents to...  
WO/2007/081569A3
Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atheros...  
WO/2007/078523A3
The present invention is directed to compounds of Formula I: Wherein R1, R2, Y, m and n are further defined in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employe...  
WO/2007/079186A3
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosc...  
WO/2007/079186A2
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosc...  
WO/2007/078523A2
The present invention is directed to compounds of Formula I: Wherein R1, R2, Y, m and n are further defined in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employe...  
WO/2007/074477A3
The invention provides two crystalline forms A and B of the skeletal muscle relaxant and anxiolytic agent, Metaxalone of formula (I), and a process for preparation thereof. The two crystalline forms A and B are bioavailable. The inventio...  
WO/2007/074477A2
The invention provides two crystalline forms A and B of the skeletal muscle relaxant and anxiolytic agent, Metaxalone of formula (I), and a process for preparation thereof. The two crystalline forms A and B are bioavailable. The inventio...  
WO/2007/075870A2
The application provides a process for the preparation of taxane derivatives and intermediates useful in such processes.  
WO/2007/075870A3
The application provides a process for the preparation of taxane derivatives and intermediates useful in such processes.  
WO/2007/073699A1
5,5'-linked 1,1'-biphenyl axial chiral ligands in the field of chemical engineering technique are disclosed. The present ligands have both central chirality of oxazoline and axial chirality of biphenyl. The present ligands are expected t...  
WO/2007/073518A2
Methods for therapy of cystic fibrosis and other conditions such as cancer are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system (i.e., ABC transporters s...  
WO/2007/073518A3
Methods for therapy of cystic fibrosis and other conditions such as cancer are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system (i.e., ABC transporters s...  
WO/2007/073296A1
The present invention relates to novel thiazole and oxazole derivatives having a positive allosteric GABAB receptor (GBR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a ...  
WO/2007/068815A3
The invention concerns compounds of formula (I) wherein: X represents a -C-, -SO2-, -C-N(R5)-C-N(R5)- group; Y represents an oxygen atom or a sulphur atom; R1 represents a hydrogen atom or a C1-C4 alkyl group; R2 represents a C1-C7 alkyl...  
WO/2007/069773A1
The present invention provides a novel modulator of the TRPV1-receptor function, comprising a compound of the formula; wherein ring A is an optionally substituted carbocycle or heterocycle, ring B is an optionally substituted benzene rin...  
WO/2007/068815A2
The invention concerns compounds of formula (I) wherein: X represents a -C-, -SO2-, -C-N(R5)-C-N(R5)- group; Y represents an oxygen atom or a sulphur atom; R1 represents a hydrogen atom or a C1-C4 alkyl group; R2 represents a C1-C7 alkyl...  
WO/2007/065821A1
The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of formula (I) and pharmace...  
WO/2007/066617A1
Disclosed is a method for producing an azoline compound represented by the general formula (3) below, which is characterized in that a carboxylic acid or a carboxylic acid derivative represented by the general formula (1) below is reacte...  
WO/2007/065828A1
The present invention relates to compounds of formula (I) wherein A, X, R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of formula I and phar...  
WO/2007/067501A1
A process for the enantio selective synthesis of an (S)- or (R)- l-[2- dimethylamino)-l-(methoxyphenyl)ethyl]cyclohexanol and analogues or salt thereof are described. The method involves the steps of (a) reacting an (S) or (R) 4- benzylo...  
WO/2007/063789A1
Disclosed are a compound having a strong COMT inhibitory effect and represented by the general formula (I) below, a pharmacologically acceptable salt thereof, a pharmaceutical composition containing either of them, and uses of them. (I) ...  
WO/2007/063839A1
Disclosed is a cyclohexane derivative represented by the formula (I), which can bind specifically to an NR1/NR2B receptor and therefore can be used as an analgesic agent (a therapeutic agent for pain): (I) wherein A1 represents a (substi...  
WO/2007/063702A3
The compound (I) or a salt thereof has an excellent controlling activity against pests. Then the compound (I) or a salt thereof is useful for an active ingredient of a pesticidal composition.  
WO/2007/064818A1
The present invention provides an isolated linezolid impurity, desfluoro linezolid, the preparation thereof and its use as a reference standard.  
WO/2007/064749A1
This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, aggrecanase, ADMP, LpxC, ADAMs, T...  
WO/2007/064316A1
The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. ...  
WO/2007/063946A1
It is intended to provide a diagnostic which specifically binds to an amyloid aggregate or deposit and thus enables the visualization or quantification of a disease caused by the amyloid aggregation and/or deposition. Namely, a compound ...  
WO/2007/060121A1
The present invention relates to Indanyl- and Tetrahydronaphthyl-amino-azoline compounds of formula (I) wherein the variables R1 and R2 are as defined in description. The invention relates also to methods of combating or controlling inse...  
WO/2007/060526A1
The invention relates to substituted azacycloalkaÏ€e compounds useful in treating conditions of the Central Nervous System (CNS); a pharmaceutical composition comprising same; a method of treating such conditions and of treating conditio...  
WO/2007/062316A2
A compound of Formula I is disclosed, in which R is a substituent containing a hydrogen bond-forming atom within three atoms from the ring carbon to which the substituent is bonded; X is CH2, 0, S or NR1, wherein Rl is a hydrocarbyl grou...  
WO/2007/062316A3
A compound of Formula I is disclosed, in which R is a substituent containing a hydrogen bond-forming atom within three atoms from the ring carbon to which the substituent is bonded; X is CH2, 0, S or NR1, wherein Rl is a hydrocarbyl grou...  

Matches 1,001 - 1,050 out of 12,188